Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Obesity, Appetite Control & Diabetes

Obesity, Appetite Control & Diabetes

Satiety, appetite, and craving are CNS drives, whereas metabolism and energy utilization are peripheral endocrine actions.
Stephen M. Stahl, M.D., Ph.D. read more

7 Items

per page
  1. Glucagon (19-29), human
    A1019 Glucagon (19-29), human
    Summary: Potent Ca2+/Mg2+-ATPase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥135.2 mg/mL
  2. a-MSH, amide
    A1025 a-MSH, amide
    Summary: Melanocyte-stimulating hormones
      insoluble in EtOH; ≥10.44 mg/mL
  3. Endomorphin-1
    A1013 Endomorphin-1
    Summary: Agonist of μopioid receptors,highly potent and selective
      ≥14.9 mg/mL
  4. LEP (116-130) (mouse)
    A1024 LEP (116-130) (mouse)
    Summary: An antiobesity hormone
      insoluble in EtOH; ≥156 mg/mL
  5. Melanocyte stimulating hormone release inhibiting factor
    A1121 Melanocyte stimulating hormone release inhibiting factor
    Summary: MSH release-inhibiting factor
      ≥59.1 mg/mL
  6. Peptide YY(3-36), PYY, human
    A1115 Peptide YY(3-36), PYY, human
    Target: NPY Receptors
    Summary: Y2R agonist
      ≥405 mg/mL
  7. Agouti-related Protein (AGRP) (25-82), human
    A1134 Agouti-related Protein (AGRP) (25-82), human
    Target: Melanocortin (MC) Receptors
    Summary: Agouti-related peptide(25-82)
      insoluble in EtOH; insoluble in DMSO; ≥100 mg/mL

7 Items

per page